Peginterferon - - Interim 12-Week Data Suggest At Least Comparable Antiviral ...

- Interim 12-Week Data Suggest At Least Comparable Antiviral ...
PR Newswire (press release), NY - Mar 14, 2006... The fourth treatment group serves as the active control group and receives 180-mcg doses of subcutaneously administered peginterferon alfa-2a (Pegasys) at 7 ...

MIGENIX to Present at BIO 2006
Yahoo! News (press release) - 4 hours ago... oral a-glucosidase I inhibitor for the treatment of chronic hepatitis C virus infections currently enrolling patients in combination with peginterferon alfa-2b ...

Gastroenterology issues probed
Trade Arabia, Bahrain - Apr 1, 2006... The study suggests that combination peginterferon alpha-2a (Pegasys) and Ribavirin is safely tolerated and effective at achieving eradication of Hepatitis C in ...

Valeant Pharmaceuticals Reports VISER1 Results for Viramidine(R) ...
Genetic Engineering News, NY - Mar 21, 2006... 1) NGI SuperQuant Assay, sensitivity to 39 IU/mL (100 copies/mL) (2) Defined as patients receiving 90% of peginterferon doses, 90% of ribavirin or Viramidine ...

Idenix Announces Thirteen Data Presentations at the 2006 European ...
PR Newswire (press release), NY - Mar 17, 2006... Dr. Zhou will present "Absence of Pharmacokinetic Drug-Drug Interaction Between Telbivudine and Peginterferon alfa-2a or Cyclosporine in Healthy Subjects" in ...